Washington (July 19, 2018): The US Food and Drug Administration(FDA) is recalling some Chinese medicines commonly used to help control blood pressure for containing a chemical that’s used to induce cancer in lab rats.
Zhejiang Huahai Pharmaceutical Co. of China inadvertently exposed one ingredient, Valsartan, to an organic chemical called N-nitrosodimethylamine (NDMA).That chemical is considered a probable carcinogen.According to details, this chemical can be toxic for the liver and other organs. There are well-documented reasons to be worried about NDMA, not least of all its use as a poison in a number of crimes.
The recall applies to three companies: Major Pharmaceuticals, Solco Healthcare, and Teva Pharmaceuticals Industries Ltd.According to an international report, this recall is particularly complicated because use of drugs with Valsartan is so widespread. The FDA’s drug- shortages team is working to find ways to ensure there will still be an adequate supply.